Publication | Closed Access

Third-line treatment for overactive bladder: should mirabegron be tried before intravesical botulinum toxin A therapy?

Urological ResearchUrologyVoiding DysfunctionSurgeryUrogynecologyThird-line TreatmentMedicineIntravesical Botulinum ToxinOveractive Bladder